 |
 |
 |
|
Trosunilimab Safety, Pharmacokinetics and Pharmacodynamics in Healthy People and People With HIV-1
|
|
|
CROI 2025 SF March 9-12
Franco Felizarta1, Cynthia Brinson2, Olayemi Osiyemi3, Ana Gabriela Pires dos Santos4, Mong-Jen Chen4, Preethi Krishnan4, Manal Abunimeh4, Harsh Sharthiya4, Heide Betman4, Nael M. Mostafa4, Veronica Wangsadipura4,
Daniel E. Cohen4, Moti Ramgopal5
1Private Practice, Bakersfield, CA, USA; 2Central Texas Clinical Research, Austin, TX, USA; 3Triple O Research Institute, West Palm Beach, FL, USA; 4AbbVie Inc., North Chicago, IL, USA; 5Midway Research Center, Fort Pierce, FL, USA






|
|
|
 |
 |
|
|